Hantgo.com

Stay Informed Stay Ahead

    • Medicine

    Rimkus acquires Human Factors Consulting Services

    admin Posted on

    Rimkus Consulting Group has announced the acquisition of Human Factors Consulting Services, Incorporated (“HFCSI”), a highly regarded firm specialising in proactive human factors services and medical device consulting.

    This acquisition strengthens Rimkus’s position as a leader in the human factors consulting industry, expanding its technical expertise and enhancing its client offerings.

    “HFCSI’s deep specialisation in human factors engineering and medical device consulting complements our own expertise and enhances our ability to deliver holistic solutions to clients worldwide. The synergies between Rimkus and HFCSI will drive continued success as we work together to solve complex challenges,” said Charles Burhans, senior vice president, specialty services, at Rimkus.

    HFCSI is known for its exceptional contributions in human factors engineering, offering proactive services including user-centred design, usability testing, and risk assessments. Their expertise in medical device consulting will provide Rimkus with new opportunities to further expand its capabilities within the medical and healthcare industries. HFCSI will join the Rimkus Family of Companies as part of the Core Human Factors (Core) group. The Core team of human factors analysis experts provides research and guidance on consumer, industrial, and healthcare-related products.

    “We are thrilled to join the Rimkus family as a global leader in engineering and technical consulting. This partnership allows us to maintain high standards of quality, while expanding our offerings and increasing efficiencies to boot. It’s a win-win scenario that will further benefit our clients, team members, and most of all the end users,” said Mike Kasamanian, president at HFCSI.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Medicine

    Aramex Scoop Sustainability AwardGlobal logistics giant Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very best in innovation and sustainability from those that are directly involved in the design, development or distribution of pharmaceuticals – a sector in which Aramex has a significant footprint. Despite being up against fierce competition within their selected category, the judges ruled that Aramex’s unwavering commitment to sustainability, environmental stewardship, and mitigating climate risks were what tipped the scales on the night. Citing a 42% reduction based on scope 1 & 2 and a 25% reduction on scope 3, dependent on supplier commitment, Aramex has since 2006 implemented a multifaceted climate change mitigation strategy with the sole aim of minimising its carbon footprint and improving its impact on the environment. This strategy involves investment into renewable energy projects, commitment to minimising waste and promoting recycling across its network, enhancing energy efficiency across its operations, with initiatives such as ISO 14001 certification, LEED certification for its facilities along with further energy efficiency projects to drive down usage. Reduced water consumption, route optimisation projects to reduce fuel consumption and emissions, and a commitment to gradually transitioning its fleet to electric and low-emission vehicles have also been put in place. Aramex has also implemented its Future Vehicle Program which explores innovative solutions such as autonomous vehicles and drone deliveries to enhance efficiency and reduce environmental impact in the years to come. Ronan Kitchin who heads up the Life Science and Healthcare division at Aramex UK commented: “We are delighted to have been recognised by Distributing Pharmaceuticals at their recent award event for our work in driving sustainability initiatives throughout our distribution services – a commitment which we have made significant strides towards over the past two decades. “With a legacy of championing sustainability, our environmental and climate change mitigation strategy looks to deliver tangible and positive changes in reducing emissions across the entire business – whether that be in our efforts to minimise waste or reducing fuel consumption. Ensuring our footprint is kept at a minimum where possible is at the top of our agenda and we couldn’t be prouder that this has been recognised by an independent panel of respected industry experts within the pharmaceutical industry – a sector within which we have a long and proud history serving. “Ultimately, it’s about doing the right thing. The world is undergoing a rate of change which is incomparable to anything humankind has ever faced before and therefore all need to play their part if the collective goal of defeating the worsening climate crisis is to be achieved. A huge thanks must therefore go out to all team members across the Aramex network who have each played a part in helping the company make such incredible inroads in its own sustainability goals.”

    admin
    Slot gacor maxwin
    Slot88
    TOGEL ONLINE